February 15, 2013
(from right) Mr Nakayama, Prof. Matsuo and Kimikazu Noumi, CEO of the INCJ Daiichi Sankyo said on February 14 that it will set up a new company in March that will develop a nucleic acid drug for the treatment of...read more